Judith A Tate1, Beth E Snitz, Karina A Alvarez, Richard L Nahin, Lisa A Weissfeld, Oscar Lopez, Derek C Angus, Faraaz Shah, Diane G Ives, Annette L Fitzpatrick, Jeffrey D Williamson, Alice M Arnold, Steven T DeKosky, Sachin Yende. 1. 1Department of Acute and Tertiary Care, School of Nursing, University of Pittsburgh, Pittsburgh, PA. 2Department of Neurology, University of Pittsburgh, Pittsburgh, PA. 3Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA. 4National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health, Bethesda, MD. 5The Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, University of Pittsburgh, Pittsburgh, PA. 6Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA. 7Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA. 8Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA. 9Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA. 10Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC. 11Department of Biostatistics, University of Washington, Seattle, WA. 12School of Medicine, University of Virginia, Charlottesville, VA.
Abstract
OBJECTIVES: Severe infections, often requiring ICU admission, have been associated with persistent cognitive dysfunction. Less severe infections are more common and whether they are associated with an increased risk of dementia is unclear. We determined the association of pneumonia hospitalization with risk of dementia in well-functioning older adults. DESIGN: Secondary analysis of a randomized multicenter trial to determine the effect of Gingko biloba on incident dementia. SETTING:Five academic medical centers in the United States. SUBJECTS:Healthy community volunteers (n = 3,069) with a median follow-up of 6.1 years. INTERVENTIONS: None. MEASUREMENT AND MAIN RESULTS: We identified pneumonia hospitalizations using International Classification of Diseases, 9th Edition-Coding Manual codes and validated them in a subset. Less than 3% of pneumonia cases necessitated ICU admission, mechanical ventilation, or vasopressor support. Dementia was adjudicated based on neuropsychological evaluation, neurological examination, and MRI. Two hundred twenty-one participants (7.2%) incurred at least one hospitalization with pneumonia (mean time to pneumonia = 3.5 yr). Of these, dementia was developed in 38 (17%) after pneumonia, with half of these cases occurring 2 years after the pneumonia hospitalization. Hospitalization with pneumonia was associated with increased risk of time to dementia diagnosis (unadjusted hazard ratio = 2.3; CI, 1.6-3.2; p < 0.0001). The association remained significant when adjusted for age, sex, race, study site, education, and baseline mini-mental status examination (hazard ratio = 1.9; CI, 1.4-2.8; p < 0.0001). Results were unchanged when additionally adjusted for smoking, hypertension, diabetes, heart disease, and preinfection functional status. Results were similar using propensity analysis where participants with pneumonia were matched to those without pneumonia based on age, probability of developing pneumonia, and similar trajectories of cognitive and physical function prior to pneumonia (adjusted prevalence rates, 91.7 vs 65 cases per 1,000 person-years; adjusted prevalence rate ratio = 1.6; CI, 1.06-2.7; p = 0.03). Sensitivity analyses showed that the higher risk also occurred among those hospitalized with other infections. CONCLUSION:Hospitalization with pneumonia is associated with increased risk of dementia.
RCT Entities:
OBJECTIVES:Severe infections, often requiring ICU admission, have been associated with persistent cognitive dysfunction. Less severe infections are more common and whether they are associated with an increased risk of dementia is unclear. We determined the association of pneumonia hospitalization with risk of dementia in well-functioning older adults. DESIGN: Secondary analysis of a randomized multicenter trial to determine the effect of Gingko biloba on incident dementia. SETTING: Five academic medical centers in the United States. SUBJECTS: Healthy community volunteers (n = 3,069) with a median follow-up of 6.1 years. INTERVENTIONS: None. MEASUREMENT AND MAIN RESULTS: We identified pneumonia hospitalizations using International Classification of Diseases, 9th Edition-Coding Manual codes and validated them in a subset. Less than 3% of pneumonia cases necessitated ICU admission, mechanical ventilation, or vasopressor support. Dementia was adjudicated based on neuropsychological evaluation, neurological examination, and MRI. Two hundred twenty-one participants (7.2%) incurred at least one hospitalization with pneumonia (mean time to pneumonia = 3.5 yr). Of these, dementia was developed in 38 (17%) after pneumonia, with half of these cases occurring 2 years after the pneumonia hospitalization. Hospitalization with pneumonia was associated with increased risk of time to dementia diagnosis (unadjusted hazard ratio = 2.3; CI, 1.6-3.2; p < 0.0001). The association remained significant when adjusted for age, sex, race, study site, education, and baseline mini-mental status examination (hazard ratio = 1.9; CI, 1.4-2.8; p < 0.0001). Results were unchanged when additionally adjusted for smoking, hypertension, diabetes, heart disease, and preinfection functional status. Results were similar using propensity analysis where participants with pneumonia were matched to those without pneumonia based on age, probability of developing pneumonia, and similar trajectories of cognitive and physical function prior to pneumonia (adjusted prevalence rates, 91.7 vs 65 cases per 1,000 person-years; adjusted prevalence rate ratio = 1.6; CI, 1.06-2.7; p = 0.03). Sensitivity analyses showed that the higher risk also occurred among those hospitalized with other infections. CONCLUSION: Hospitalization with pneumonia is associated with increased risk of dementia.
Authors: K Rockwood; I Parhad; V Hachinski; T Erkinjuntti; B Rewcastle; A Kertesz; M R Eastwood; S Phillips Journal: Can J Neurol Sci Date: 1994-11 Impact factor: 2.104
Authors: Colm Cunningham; Suzanne Campion; Katie Lunnon; Carol L Murray; Jack F C Woods; Robert M J Deacon; J Nicholas P Rawlins; V Hugh Perry Journal: Biol Psychiatry Date: 2008-09-18 Impact factor: 13.382
Authors: Sachin Kale; Sachin Yende; Lan Kong; Amy Perkins; John A Kellum; Anne B Newman; Abbe N Vallejo; Derek C Angus Journal: PLoS One Date: 2010-11-04 Impact factor: 3.240
Authors: Sachin Yende; Derek C Angus; Ibrahim Sultan Ali; Grant Somes; Anne B Newman; Douglas Bauer; Melissa Garcia; Tamara B Harris; Stephen B Kritchevsky Journal: J Am Geriatr Soc Date: 2007-04 Impact factor: 5.562
Authors: Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg Journal: JAMA Date: 2008-11-19 Impact factor: 56.272
Authors: Oscar L Lopez; Lewis H Kuller; Annette Fitzpatrick; Diane Ives; James T Becker; Norman Beauchamp Journal: Neuroepidemiology Date: 2003 Jan-Feb Impact factor: 3.282
Authors: Faraaz Ali Shah; Francis Pike; Karina Alvarez; Derek Angus; Anne B Newman; Oscar Lopez; Judith Tate; Vishesh Kapur; Anthony Wilsdon; Jerry A Krishnan; Nadia Hansel; David Au; Mark Avdalovic; Vincent S Fan; R Graham Barr; Sachin Yende Journal: Am J Respir Crit Care Med Date: 2013-09-01 Impact factor: 21.405
Authors: Rod A Rahimi; Josalyn L Cho; Claudia V Jakubzick; Shabaana A Khader; Bart N Lambrecht; Clare M Lloyd; Ari B Molofsky; Sebastien Talbot; Catherine A Bonham; Wonder P Drake; Anne I Sperling; Benjamin D Singer Journal: Am J Respir Cell Mol Biol Date: 2022-07 Impact factor: 7.748
Authors: Timothy D Girard; Wesley H Self; Kathryn M Edwards; Carlos G Grijalva; Yuwei Zhu; Derek J Williams; Seema Jain; James C Jackson Journal: J Gen Intern Med Date: 2018-01-26 Impact factor: 5.128
Authors: Keenan A Walker; Rebecca F Gottesman; Aozhou Wu; David S Knopman; Thomas H Mosley; Alvaro Alonso; Anna Kucharska-Newton; Charles H Brown Journal: J Am Geriatr Soc Date: 2018-09-24 Impact factor: 5.562